Difference between revisions of "Team:Queens Canada/Interviews"

Line 17: Line 17:
 
<h3>Dr. Andrea Guerin <br>Department of Pediatrics, Queen’s University School of Medicine<h3>
 
<h3>Dr. Andrea Guerin <br>Department of Pediatrics, Queen’s University School of Medicine<h3>
 
<img src="https://static.igem.org/mediawiki/2018/2/2f/T--Queens_Canada--Dr_Andrea_Guerin.jpeg/>
 
<img src="https://static.igem.org/mediawiki/2018/2/2f/T--Queens_Canada--Dr_Andrea_Guerin.jpeg/>
 +
</div>
 
<p>Dr. Andrea Guerin is a full time Assistant Professor in Pediatrics and Medical Geneticist. She is the Year 2 Director at Queen’s University Medical School. Her work in Medical Genetics includes a consultation practice consisting of general genetics, prenatal genetics, cancer genetics and the care of patients with inborn errors of metabolism. Interviewing Dr. Guerin was a great opportunity to hear her thoughts on the pros, cons, and potential applications of using cortisol as a useful biomarker, including revelations on hypoglycemia, insulinemia, and early diagnosis of developmental disabilities. In terms of the pacifier model, she suggested potential use of a saliva collection device, which would work well as a non-invasive method of collecting DNA from infants to do genetic testing. As well, Dr. Guerin found value in the modular design of our ligand detection system and offered the potential of looking at glucose and bilirubin as other relevant metabolites in the pediatric field.</p><br>
 
<p>Dr. Andrea Guerin is a full time Assistant Professor in Pediatrics and Medical Geneticist. She is the Year 2 Director at Queen’s University Medical School. Her work in Medical Genetics includes a consultation practice consisting of general genetics, prenatal genetics, cancer genetics and the care of patients with inborn errors of metabolism. Interviewing Dr. Guerin was a great opportunity to hear her thoughts on the pros, cons, and potential applications of using cortisol as a useful biomarker, including revelations on hypoglycemia, insulinemia, and early diagnosis of developmental disabilities. In terms of the pacifier model, she suggested potential use of a saliva collection device, which would work well as a non-invasive method of collecting DNA from infants to do genetic testing. As well, Dr. Guerin found value in the modular design of our ligand detection system and offered the potential of looking at glucose and bilirubin as other relevant metabolites in the pediatric field.</p><br>
  

Revision as of 18:32, 28 July 2018

Expert Interviews

Dr. Andrea Guerin
Department of Pediatrics, Queen’s University School of Medicine